Effect of Chinese Patent Medicine Naodesheng against Repeated Transient Global Cerebral Ischemia in Mice
10.1016/S1674-6384(15)60062-4
- Author:
Chun-Hua HAO
1
Author Information
1. State Key Laboratory of Pharmacokinetics and Pharmacodynamics, Tianjin Institute of Pharmaceutical Research
- Publication Type:Journal Article
- Keywords:
Naodesheng;
Repeated transient global cerebral ischemia;
Vascular dementia
- From:
Chinese Herbal Medicines
2015;7(4):339-343
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the therapeutic effect and possible mechanisms of Chinese ptent medicine Naodesheng (NDS) on repeated transient global cerebral ischemia (GCI) in mice. Methods: The repeated transient GCI mice were induced by bilateral carotid arteries ligation, and were randomly divided into model group, Sham group without arteries ligation, NDS groups (1.25 and 2.5 g/kg) and positive control (vinpocetine 3.1 mg/kg, VP) group. After oral administration once daily for successive 7 d, the transient GCI was induced. The degree of neurological deficit, histological changes, and neurons loss in the hippocampus were evaluated. In order to investigate the possible mechanisms, the oxidative stress and inflammatory factor were measured after 24 h of GCI. Comparison among multiple groups was performed with one-way analysis of variance (ANOVA). Results: NDS could significantly alleviate the neurological function impairment, histological injury, and neurons loss, increase the superoxide dismutase (SOD) activity, decrease the content of malondialdehyde (MDA), and reduce inflammatory factor in the ischemic brain tissue. Conclusion: NDS could significantly reduce brain injury induced by global ischemia, and its mechanism is closely associated with anti-oxidation and anti-inflammation.
